US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

JASPER THERAPEUTICS INC C/WTS 24/09/2026 (TO PUR COM)

0.0172

-0.0011-6.01%

Post-market: 0.01720.00000.00%16:59 EST

Volume:332.00

Turnover:5.97

Market Cap:215.00K

PE:0.00

High:0.0183

Open:0.0183

Low:0.0172

Close:0.0183

52wk High:0.1775

52wk Low:0.0166

Shares:12.50M

Float Shares:- -

Volume Ratio:0.05

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-5.9031

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Company Profile

Company Name:

JASPER THERAPEUTICS INC C/WTS 24/09/2026 (TO PUR COM)

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.jaspertherapeutics.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of therapeutic agents for diseases, such as chronic spontaneous urticaria, lower to intermediate risk myelodysplastic syndrome, and novel conditioning regimens for stem cell transplantation and ex-vivo gene therapy, a technique in which genetic manipulation of cells is performed outside of the body prior to transplantation. The company's lead product candidate is briquilimab, which is in clinical development as a novel therapeutic antibody that clears hematopoietic stem cells from bone marrow in patients prior to undergoing allogeneic stem cell therapy or stem cell gene therapy. It is also developing engineered hematopoietic stem cells product candidates to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. The company is headquartered in Redwood City, California.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/JSPRW/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"JSPRW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JSPRW\",,,,,undefined,":{"symbol":"JSPRW","market":"US","secType":"STK","nameCN":"JASPER THERAPEUTICS INC C/WTS 24/09/2026 (TO PUR COM)","latestPrice":0.0172,"timestamp":1771621200000,"preClose":0.0183,"halted":0,"volume":332,"hourTrading":{"tag":"盘后","latestPrice":0.0172,"preClose":0.0172,"latestTime":"16:59 EST","volume":1,"amount":0.0186,"timestamp":1771624792105,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.06010928961748635,"floatShares":0,"shares":12500000,"eps":-5.9031,"marketStatus":"Market Closed","change":-0.0011,"latestTime":"02-20 16:00:00 EST","open":0.0183,"high":0.0183,"low":0.0172,"amount":5.974595972,"amplitude":0.060109,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.9031,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":0.0183,"postHourTrading":{"tag":"盘后","latestPrice":0.0172,"preClose":0.0172,"latestTime":"16:59 EST","volume":1,"amount":0.0186,"timestamp":1771624792105,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.04916479031909974},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JSPRW\",,,,,undefined,":{"symbol":"JSPRW","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.04916479031909974,"shares":12500000,"dividePrice":0,"high":0.0183,"amplitude":0.060109,"preClose":0.0183,"low":0.0172,"week52Low":0.0166,"pbRate":"--","week52High":0.1775,"institutionHeld":0,"latestPrice":0.0172,"eps":-5.9031,"divideRate":0,"volume":332,"delay":0,"ttmEps":-5.9031,"open":0.0183,"prevYearClose":0.0401,"prevWeekClose":0.0189,"prevMonthClose":0.0341,"prevQuarterClose":0.0401,"fiveDayClose":0.0189,"twentyDayClose":0.0247,"sixtyDayClose":0.125},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/JSPRW\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"JSPRW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"JSPRW\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.jaspertherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0899},{"period":"1month","weight":-0.5024},{"period":"3month","weight":-0.8624},{"period":"6month","weight":-0.8045},{"period":"1year","weight":-0.8918},{"period":"ytd","weight":-0.5711}],"compareEarnings":[{"period":"1week","weight":0.0113},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0461},{"period":"6month","weight":0.0684},{"period":"1year","weight":0.1295},{"period":"ytd","weight":0.011}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of therapeutic agents for diseases, such as chronic spontaneous urticaria, lower to intermediate risk myelodysplastic syndrome, and novel conditioning regimens for stem cell transplantation and ex-vivo gene therapy, a technique in which genetic manipulation of cells is performed outside of the body prior to transplantation. The company's lead product candidate is briquilimab, which is in clinical development as a novel therapeutic antibody that clears hematopoietic stem cells from bone marrow in patients prior to undergoing allogeneic stem cell therapy or stem cell gene therapy. It is also developing engineered hematopoietic stem cells product candidates to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. The company is headquartered in Redwood City, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.544492},{"month":2,"riseRate":0.428571,"avgChangeRate":0.002585},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.108025},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.144526},{"month":5,"riseRate":0.666667,"avgChangeRate":0.074401},{"month":6,"riseRate":0.833333,"avgChangeRate":0.070897},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.112616},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.061335},{"month":9,"riseRate":0.5,"avgChangeRate":0.039126},{"month":10,"riseRate":0.333333,"avgChangeRate":0.171145},{"month":11,"riseRate":0.5,"avgChangeRate":0.033751},{"month":12,"riseRate":0.666667,"avgChangeRate":-0.095292}],"exchange":"NASDAQ","name":"JASPER THERAPEUTICS INC C/WTS 24/09/2026 (TO PUR COM)","nameEN":"JASPER THERAPEUTICS INC C/WTS 24/09/2026 (TO PUR COM)"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"JSPRW\",market:\"US\",,,undefined,":null}}